Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

IGEM raises L2M in series A

June 23, 2017 8:29 PM UTC

On June 20, immuno-oncology company IGEM Therapeutics Ltd. (Reading, U.K.) raised £2 million ($2.6 million) in a series A round from Epidarex Capital....

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Epsilogen Ltd.